The RaLGTPase Regulatory Network
RaLGTPase 监管网络
基本信息
- 批准号:8119390
- 负责人:
- 金额:$ 23.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-07 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdhesionsAnimalsBiological ModelsCell DeathCell ProliferationCell SurvivalCell physiologyCellsChronicFamilyGTP-Binding ProteinsGuanosine Triphosphate PhosphohydrolasesMediatingMolecularNatureOncogenicPathway interactionsRegulationSignal TransductionXenograft procedurebasecancer cellral A GTP-Binding Proteinrestrainttumor initiationtumor progressiontumorigenic
项目摘要
DESCRIPTION (provided by applicant): Accumulating evidence from both cell and animal-based model systems indicates the Ras-like small GTP-binding proteins RalA and RalB are core components of a regulatory framework supporting tumorigenic transformation. Recently we have established discrete but interlocking contributions of these highly related G-proteins to the regulation of both cancer and cell proliferation and survival. Specifically, chronic activation of RalA is required to maintain anchorage-independent proliferation, while RalB is required to deflect cell-death checkpoint activation. This proposal is directed at defining the composition, organization, and function of cell regulatory networks engaged by Ral family G-proteins. Our focus is on the dominant RalA and RalB effector pathways that directly participate in oncogenic transformation. Our specific aims are 1) identification of the effector pathway(s) mediating RalA support of anchorage-independent proliferation, 2) defining the mechanistic contribution of RalB signaling to cancer cell survival, and 3) evaluating the consequences of perturbations in RalA/RalB signaling networks to tumor initiation and/or progression in xenograft and organotypic model systems.
描述(申请人提供):来自细胞和动物模型系统的积累证据表明,RAS样小GTP结合蛋白Rala和RalB是支持肿瘤形成转化的调控框架的核心组件。最近,我们已经确定了这些高度相关的G蛋白对癌症、细胞增殖和生存的调节作用是离散的,但又是相互关联的。具体地说,Rala的慢性激活是维持锚定非依赖性增殖所必需的,而RalB则需要转移细胞死亡检查点的激活。这项建议旨在定义由Ral家族G蛋白参与的细胞调控网络的组成、组织和功能。我们的重点是直接参与致癌转化的主要Rala和RalB效应通路。我们的具体目标是1)确定介导Rala支持锚定非依赖增殖的效应通路(S),2)确定RalB信号对癌细胞存活的机制贡献,以及3)在异种移植和器官模型系统中评估Rala/RalB信号网络的扰动对肿瘤启动和/或进展的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL A. WHITE其他文献
MICHAEL A. WHITE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL A. WHITE', 18)}}的其他基金
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)
麦克米伦:项目 3;
- 批准号:
8881715 - 财政年份:2015
- 资助金额:
$ 23.15万 - 项目类别:
Targeting Mechanistic Subtypes of Neoplastic Disease
针对肿瘤疾病的机制亚型
- 批准号:
8955822 - 财政年份:2015
- 资助金额:
$ 23.15万 - 项目类别:
Molecular components specifying mucosal cell sensitivity to influenza infection
指定粘膜细胞对流感感染敏感性的分子成分
- 批准号:
7708002 - 财政年份:2009
- 资助金额:
$ 23.15万 - 项目类别:
Molecular components specifying mucosal cell sensitivity to influenza infection
指定粘膜细胞对流感感染敏感性的分子成分
- 批准号:
7929519 - 财政年份:2009
- 资助金额:
$ 23.15万 - 项目类别:
Deriving Combinatorial Strategies for Therapy of Pancreatic Cancer
制定胰腺癌治疗的组合策略
- 批准号:
7434534 - 财政年份:2007
- 资助金额:
$ 23.15万 - 项目类别:
Deriving Combinatorial Strategies for Therapy of Pancreatic Cancer
制定胰腺癌治疗的组合策略
- 批准号:
7255944 - 财政年份:2007
- 资助金额:
$ 23.15万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 23.15万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 23.15万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 23.15万 - 项目类别: